Transforming growth factor-β induced protein regulates pulmonary fibrosis via the G-protein signaling modulator 2

Kai Yang1, Na Huang1, Jian Sun2

  • 1Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Chengdu Medical College, No. 278, Baoguang Avenue, Xindu District, Chengdu, Sichuan 610500, China; Chengdu Medical College, No. 783, Xindu Avenue, Xindu District, Chengdu, Sichuan 610500, China.

Peptides
|July 25, 2022
PubMed

Insights

Transforming growth factor-beta induced protein (TGFBI) drives pulmonary fibrosis by altering G-protein signaling modulator 2 (GPSM2) and Snail. Targeting TGFBI offers a new therapeutic strategy for this severe lung disease.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biochemistry

Background:

  • Pulmonary fibrosis is a progressive lung disease with limited treatment options.
  • It involves fibroblast activation and excessive extracellular matrix deposition, leading to respiratory failure.
  • Novel therapeutic targets are crucial for managing pulmonary fibrosis.

Purpose of the Study:

  • To investigate the role of transforming growth factor-beta induced protein (TGFBI) in pulmonary fibrosis.
  • To elucidate the mechanism by which TGFBI regulates fibrosis, focusing on the G-protein signaling modulator 2 (GPSM2)/Snail axis.

Main Methods:

  • Utilized bleomycin-induced rat models and TGF-beta1-stimulated human lung fibroblasts (IMR-90).
  • Employed siRNA to silence TGFBI and Snail, and overexpressed GPSM2.
  • Administered TGF-beta signaling inhibitor SB431542.

Main Results:

  • TGFBI expression was upregulated, while GPSM2 was downregulated in fibrotic lung tissues and cells.
  • Silencing TGFBI or inhibiting TGF-beta signaling reduced fibrotic effects and normalized GPSM2/Snail expression.
  • GPSM2 overexpression and Snail silencing also attenuated TGF-beta1-induced fibrosis.

Conclusions:

  • TGFBI promotes pulmonary fibrosis via the GPSM2/Snail pathway.
  • TGFBI represents a novel mediator and potential therapeutic target for pulmonary fibrosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.5K